A comprehensive topical product system meticulously formulated for the targeted treatment of viral skin warts.
- General Details
Despite the established viral origin of skin warts, the effectiveness of topical antiviral treatments has been restricted. In response to this challenge, WartOlyze® was created.
- Unmatched Efficacy
WartOlyze® is a solution for treating viral warts on the skin with clinically verifiation of 100% efficacy. This high success rate is consistent across all types of viral warts, making WartOlyze® a universally applicable treatment. Whether dealing with common warts, plantar warts, or flat warts, WartOlyze® delivers unparalleled results. - Versatile Applications
Its pain-free application process ensures little to no post-procedure discomfort, making it a patient-friendly option. Patients can expect a smooth experience, free of side effects or clinical complications, which further enhances the appeal of WartOlyze®. - Long-Lasting Results
One of the standout features of WartOlyze® is its minimal recurrence rates. Patients benefit from long-lasting results, reducing the need for repeat treatments. - Economic and Practical Benefits
WartOlyze® is not only effective but also economical and commercially feasible. The swift procedures ensure rapid patient turnover, allowing clinics to treat more patients in less time. - Service Mobility
Another significant advantage of WartOlyze® is its service mobility. This feature facilitates the establishment of a network of offices offering this technique. Clinics can easily incorporate WartOlyze® into their range of services, expanding their offerings and attracting more patients.
If you are interested in WartOlyze®, please visit this link.
- Unmatched Efficacy
- Patent Portfolio
- U.S. Patent Pub. No. 20230052709 – Topical antiviral liquid for treatment of warts
- U.S. Patent App. No. 18/112,852 – Topical composition for destroying, in vivo, an external hyperplastic tissue, such as, but not limited to, a viral skin lesion, such as, but not limited to, a viral wart
- U.S. Patent App. No. 63/227,147 – Method of using a topical antiviral liquid for affecting etiological factors of viral warts
- U.S. Patent App. No. 63/227,144 – Topical antiviral liquid for affecting etiological factors of viral warts
- U.S. Patent App. No. 63/227,151 – Method for making the topical antiviral liquid for affecting etiological factors of viral warts
- WARTOLYZE® Design Mark – Reg. No. 5,601,585
- WARTOLYZE® Word Mark – Reg. No. 5,601,583
- Data Room Access & Additional Details
Other Publicly Data Room Materials Available at VIP-3307 Public Data Room for Essential Remedium IP:
- Other Introductory Materials
- Presentations
- Videos
- Non-Disclosure Agreement Draft to access more files listed below
Additional Materials (available upon signing a mutual non-disclosure agreement):
- Due Diligence Review
- Patents, Trademarks, and Applications
- Patent, Trademark, and Application File Histories
- Assignments and Ownership
- Additional Documents
- More Information
Pricing guidance for this transaction may be available. All parties interested in the IP above are authorized to contact Spencer Rogers at Vibrant IP, LLC at spencer@vibrantip.com and 415-997-9772.
